New drug duo aims to shrink lung tumors before surgery
NCT ID NCT07438600
Summary
This study is testing whether a combination of two drugs, sacituzumab govitecan and toripalimab, can shrink tumors in patients with a specific type of lung cancer before they have surgery. The goal is to see if this pre-surgery treatment helps remove more of the cancer and lowers the chance of it coming back. The study will enroll about 38 adults with stage II-IIIB non-small cell lung cancer who have not had prior cancer treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.